CompletedEarly Phase 1NCT02669225

Brain Amyloid- Retention During Wakefulness and Following Emergence From Sleep in Healthy People

Studying Amyloidosis

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Principal Investigator
Dardo G Tomasi, Ph.D.
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Intervention
[18F]florbetaben(other)
Enrollment
22 enrolled
Eligibility
18-40 years · All sexes
Timeline
2016 – 2018

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02669225 on ClinicalTrials.gov

Other trials for Amyloidosis

Additional recruiting or active studies for the same condition.

See all trials for Amyloidosis →

← Back to all trials